This combination is aimed at patients who are insulin-dependent and need additional glucose control
The TriNetX platform has been used in retrospective cohort studies [25,26,27,28,29,30,31,32,33,34,35,36,37,38] including evaluating risk and health outcomes of patients with substance use disorders including CUD [25, 32, 35] and the associations of GLP-1RAs with cancer [37] and semaglutide with suicidal ideations [38]
In future, it is likely that the clinical indications for GLP- 1RAs will expand, with pharmaceutical companies running various drug trials to substantiate a wider array of use cases, such as the reduction of cardiovascular risk and the treatment of chronic kidney disease
Needle-phobic patients who want an evidence-backed oral GLP-1 (Wegovy pill)
This is different from platforms that use flat-rate pricing regardless of dose, and it means your total cost rises over time as your treatment progresses
Tune in to Primes Pharmacy Friends podcast episode on MASH to learn more